Highlights
NASDAQ: DNLI       Denali Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
24.65   +1.25 (5.34%)  24.22 - 25.43  937,800

Overview

 
Avg Volume (4 weeks):670,388
4 Weeks Range:16.02 - 25.43
4 Weeks Price Volatility (%):
91.71%
52 Weeks Range:14.24 - 28.865
52 Weeks Price Volatility (%):
71.18%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Denali Therapeutics Inc is a biotechnology company which is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include LRRK2 Inhibitor Program which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle) and others.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers